中红医疗
(300981)
| 流通市值：62.57亿 | | | 总市值：68.28亿 |
| 流通股本：3.93亿 | | | 总股本：4.29亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,478,364,167.05 | 601,919,053.24 | 2,373,206,803.4 | 1,863,658,896.34 |
| 营业收入 | 1,478,364,167.05 | 601,919,053.24 | 2,373,206,803.4 | 1,863,658,896.34 |
| 二、营业总成本 | 1,338,013,799.24 | 610,659,330.18 | 2,451,906,534.08 | 1,889,367,380.39 |
| 营业成本 | 1,124,092,233.68 | 515,831,929.13 | 2,108,626,562.23 | 1,667,274,550 |
| 税金及附加 | 12,181,817.05 | 6,098,345.24 | 24,732,178.75 | 18,636,121.65 |
| 销售费用 | 52,901,700.71 | 25,181,697.36 | 116,517,800.38 | 89,732,911.66 |
| 管理费用 | 59,592,271.2 | 29,999,246.38 | 137,485,650.12 | 94,210,090.48 |
| 研发费用 | 25,690,182.76 | 11,910,591.03 | 51,075,427.79 | 37,187,779.66 |
| 财务费用 | 63,555,593.84 | 21,637,521.04 | 13,468,914.81 | -17,674,073.06 |
| 其中:利息费用 | 18,362,896.45 | 9,448,186.66 | 31,025,869.1 | 21,495,355.03 |
| 其中:利息收入 | 12,527,715.98 | 6,274,750.4 | 45,405,903.79 | 39,920,495.01 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 30,608,278.55 | 5,615,205.34 | 42,862,607.01 | 26,062,737.81 |
| 加:投资收益 | 22,988,860.89 | 10,413,351.79 | 26,579,311.86 | 8,761,768.44 |
| 净敞口套期收益 | - | - | 0 | - |
| 资产处置收益 | -14,740.3 | 78,729.95 | 730,748.03 | -792,071.2 |
| 资产减值损失(新) | -12,195,714.92 | -2,297,631.05 | -116,152,686.54 | -25,099,406.45 |
| 信用减值损失(新) | -2,657,317.38 | 1,000,101.73 | -12,787,534.38 | -2,511,375.33 |
| 其他收益 | 2,872,548.18 | 1,036,485.93 | 11,938,400.31 | 8,851,857.94 |
| 四、营业利润 | 181,952,282.83 | 7,105,966.75 | -125,528,884.39 | -10,434,972.84 |
| 加:营业外收入 | 2,169,167.49 | 40,324.7 | 3,714,742.22 | 2,083,617.67 |
| 减:营业外支出 | 2,272,072 | 1,245,555.1 | 2,295,046.88 | 820,260.04 |
| 五、利润总额 | 181,849,378.32 | 5,900,736.35 | -124,109,189.05 | -9,171,615.21 |
| 减:所得税费用 | 23,316,359.84 | 729,639.9 | -7,631,885.96 | 392,118.66 |
| 六、净利润 | 158,533,018.48 | 5,171,096.45 | -116,477,303.09 | -9,563,733.87 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 158,533,018.48 | 5,171,096.45 | -116,477,303.09 | -9,563,733.87 |
| 终止经营净利润 | - | - | 0 | - |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 158,641,517.03 | 4,930,231.95 | -112,383,173.38 | -7,210,152.72 |
| 少数股东损益 | -108,498.55 | 240,864.5 | -4,094,129.71 | -2,353,581.15 |
| 扣除非经常损益后的净利润 | 115,248,486.3 | -2,352,697.57 | -176,831,832.28 | -37,344,922.5 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.37 | 0.01 | -0.26 | -0.02 |
| (二)稀释每股收益 | 0.37 | 0.01 | -0.26 | -0.02 |
| 八、其他综合收益 | -14,223,119 | -9,067,395.09 | -3,551,825.59 | -1,059,948.56 |
| 归属于母公司股东的其他综合收益 | -12,021,852.41 | -7,692,652.14 | -3,866,965.79 | -1,035,403.26 |
| 九、综合收益总额 | 144,309,899.48 | -3,896,298.64 | -120,029,128.68 | -10,623,682.43 |
| 归属于母公司股东的综合收益总额 | 146,619,664.62 | -2,762,420.19 | -116,250,139.17 | -8,245,555.98 |
| 归属于少数股东的综合收益总额 | -2,309,765.14 | -1,133,878.45 | -3,778,989.51 | -2,378,126.45 |
| 公告日期 | 2026-08-26 | 2026-04-27 | 2026-04-27 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |